Genmab

Prezzo Delle Azioni
1,832.50
Cambio Giornaliero
-21.00 -1.13%
Mensile
-13.15%
Annuale
14.67%
Q1 Previsione
1,757.86




Ebitda Cambiamento Data
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
argenx SE USD 288.02M 84.53M 2025-06
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.51B 1.28B 2025-09
BioMarin Pharmaceutical USD -5.26M 300.71M 2025-09
Demant DKK 2.76B 165M 2025-12
Exelixis USD 248.93M 28.02M 2025-09
Fresenius Medical Care EUR 931.26M 60.26M 2025-09
Galapagos EUR -158.71M 177.84M 2025-03
Genmab DKK 477M 101M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
GN Store Nord DKK 627M 106M 2025-12
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -314.19M 31.48M 2025-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.46B 45M 2025-06
Novartis USD 5.88B 290M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
UCB EUR 1.03B 334M 2025-06


Genmab - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.